Introducing AccurKardia, the groundbreaking startup revolutionizing remote cardiac care with its automated clinical-grade ECG interpretation software. Founded by the visionary Juan C Jimenez, the company has already raised an impressive $5.9M in Seed funding. With a focus on expanding access to cardiac monitoring worldwide, AccurKardia delivers near-real time ECG analytics in the cloud, on devices, and at the edge, utilizing a unique blend of proprietary AI and non-AI techniques. Their device-agnostic approach allows compatibility with any suitable device, from holter monitors to consumer wearables.

What sets AccurKardia apart is its clinical-grade accuracy, providing critical information in minutes, not days, with unparalleled performance adhering to the most robust international standards. As part of Mayo Clinic Platform_Accelerate's Cohort 3 and with their first 510(k) filing under FDA review, AccurKardia is poised to transform the landscape of cardiac monitoring for millions of patients globally.